Clinical Trial

Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study

Study acronym: TTVR-AHI
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
TTVR-AHI is a multicenter, retrospective registry including heart failure patients displaying a severe and symptomatic tricuspid regurgitation (TR), deemed non-eligible to cardiac surgery and therefore treated with transcatheter tricuspid valve replacement (TTVR) devices. This substudy of the main registry will focus on those with post-procedural acute hemodynamic instability (AHI).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-24; most recent amendment 2026-02-10.
Trial Details
NCT Number NCT06954792
Lead Sponsor Columbia University
Conditions Tricuspid Regurgitation, Heart Failure, Structural Heart Disease, Interventional Cardiology
Enrollment 140 participants
Start Date 2027-01
Primary Completion 2029-05-01 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12